背景:研究发现,与健康个体相比,炎症性肠病(IBD)患者并发焦虑和抑郁的风险更高。如果不及时治疗,IBD患者并发抑郁和焦虑可导致较差的健康状况和增加的医疗保健利用率。这项工作的目标是制定共识声明,以开始解决患者和提供者与IBD患者抑郁和焦虑症状的筛查和治疗相关的需求和责任。
方法:进行文献扫描以收集基于证据的背景信息和筛查建议,诊断,以及IBD患者焦虑和抑郁的治疗。随后,由IBD和心理健康专家和患者倡导者组成的小组使用改进的Delphi程序来综合文献并将信息提炼成一组核心陈述,以支持提供者的行动和护理提供。
结果:从与一般管理相关的文献和共识过程中提取了六项陈述,筛选,以及IBD患者焦虑和抑郁的治疗。
结论:对IBD患者的心理健康和支持至关重要;本文中包含的陈述代表了IBD医疗保健专业人员在解决提供者意识方面的关键问题时的实际考虑。知识和行为,筛查和治疗资源,和病人的教育。
这项工作旨在就炎症性肠病患者的焦虑和抑郁的筛查和治疗达成共识。进行了文献扫描,专家小组制定了实用的声明,以指导炎症性肠病医疗保健专业人员。
BACKGROUND: Studies have found a higher risk of comorbid anxiety and depression among patients with inflammatory bowel disease (
IBD) compared with healthy individuals. If left untreated, comorbid depression and anxiety in patients with
IBD can lead to poorer health outcomes and an increased healthcare utilization. The goal of this work was to develop a
consensus statement to begin to address patient and provider needs and responsibilities related to screening and treatment of depression and anxiety symptoms among patients with IBD.
METHODS: A literature scan was conducted to gather evidence-based background information and recommendations on the screening, diagnosis, and treatment of anxiety and depression in patients with IBD. This was followed by the engagement of a panel of IBD and mental health experts and patient advocates using a modified Delphi process to synthesize the literature and distill the information into a core set of statements to support provider actions and care delivery.
RESULTS: Six statements were distilled from the literature and
consensus process that link to the general management, screening, and treatment of anxiety and depression in patients with IBD.
CONCLUSIONS: Mental healthcare and support for IBD patients is critical; the statements included in this article represent practical considerations for IBD healthcare professionals in addressing key issues on provider awareness, knowledge and behaviors, screening and treatment resources, and patient education.
This work aimed to develop a
consensus statement on screening and treatment of anxiety and depression in individuals with inflammatory bowel disease. A literature scan was conducted, and an expert panel developed practical statements to guide inflammatory bowel disease healthcare professionals.